BRIEF published on 04/01/2025 at 07:20, 8 months 3 days ago Eurofins Completes Acquisition of SYNLAB's Spanish Operations Healthcare Expansion Laboratory Services Clinical Diagnostics Eurofins Acquisition SYNLAB Spain
PRESS RELEASE published on 04/01/2025 at 07:15, 8 months 3 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Eurofins successfully acquires SYNLAB's clinical diagnostics operations in Spain, strengthening its position as a leading clinical diagnostics operator in the country Acquisition Spain SYNLAB Eurofins Clinical Diagnostics
BRIEF published on 03/26/2025 at 10:19, 8 months 9 days ago Eurofins to Issue New Hybrid Bonds and Launch Tender Offer Refinancing Tender Offer Hybrid Bonds Eurofins Bioanalytical Testing
PRESS RELEASE published on 03/26/2025 at 10:14, 8 months 9 days ago Inside Information / Other news releases Eurofins to issue new hybrid bonds, launch tender offer to refinance existing bonds. Results expected on 03 April 2025. Company aims to increase average life of financing instruments Financial News Refinancing Tender Offer Hybrid Bonds Eurofins
BRIEF published on 03/24/2025 at 20:20, 8 months 11 days ago Eurofins Announces AGM Agenda and Strengthens Balance Sheet Commitment Property Acquisition Financial Leverage Eurofins AGM 2025 Gavin Hill Appointment Balance Sheet Strategy
PRESS RELEASE published on 03/24/2025 at 20:15, 8 months 11 days ago Inside Information / Other news releases Eurofins announces agenda for upcoming General Meetings, appoints new director & considers real estate purchases. Maintains commitment to strong balance sheet Investors Real Estate Balance Sheet General Meetings Eurofins
BRIEF published on 03/24/2025 at 14:41, 8 months 11 days ago Eurofins Scientific SE Announces Changes in Share Capital and Voting Rights Share Capital Voting Rights Shareholder Transparency Eurofins Scientific SE Equity Management
PRESS RELEASE published on 03/24/2025 at 14:36, 8 months 11 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Disclosure of voting rights and capital by Eurofins Scientific SE according to transparency requirements for issuers of securities Securities Voting Rights Capital Transparency Requirements Eurofins Scientific SE
BRIEF published on 03/19/2025 at 20:34, 8 months 16 days ago Eurofins Scientific SE Launches Fifth Share Buy-Back Programme Share Buy-back Investment Strategy Financial Services Long-term Incentive Eurofins
PRESS RELEASE published on 03/19/2025 at 20:29, 8 months 16 days ago Acquisition or disposal of the issuer's own shares / Description of the buyback program Eurofins Scientific SE announces its fifth buy-back programme of own shares, aiming to repurchase up to 4.5% of share capital. Programme starts on 20 March 2025 Share Capital Investor Relations Own Shares Buy-back Programme Eurofins
Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 36 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 41 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 56 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
